Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2015905220Aexternal-prioritypatent/AU2015905220A0/en
Application filed by Walter & Eliza Hall Inst Medical ResfiledCriticalWalter & Eliza Hall Inst Medical Res
Publication of NZ771657ApublicationCriticalpatent/NZ771657A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The present invention relates to therapeutic and prophylactic methods based on inhibition of CIS in NK cells. In particular, the present invention relates to treating or preventing a NK-responsive condition by administering to a subject a CIS inhibitor, or administering CIS-inhibited NK cells. The invention further relates to methods for identifying a CIS inhibitor, and for determining a likelihood of cancer response to treatment with CIS inhibition.
NZ771657A2015-12-162016-12-16Inhibition of cytokine-induced sh2 protein in nk cells
NZ771657A
(en)